…to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Ryvu Therapeutics S.A. (Warsaw Stock Exchange: RVU, “Ryvu”), a clinical-stage company developing […]
….to prioritize unhealthy cholesterol as a main public health issue The Global Heart Hub has today launched its Global Cholesterol Action Plan to reduce the […]
Negotiations Continue as Million Person Trial design advances Brainreader Inc. announced today that it is in advanced negotiations to utilize its Neuroreader® software as the […]
RELIEF THERAPEUTICS Holding SA (SIX: RLF) (OTCQB: RLFTF) (RLFTD) (“Relief”), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent protected products in selected […]
Medical technology company Scivita Medical Technology Co., Ltd. (“Scivita Medical”) looks back on an exciting week at the trade fair. Scivita Medical was able to […]
• Responds to growing global demand for biosafety testing as essential requirement for drug development and commercialization • Expansion creates more than 500 new jobs […]
– Randomized first patient in the Phase 2b EU-SolidAct platform for hospitalized COVID-19 patients –– Initiated Phase 1b/2a trial in 1st line NSCLC patients harboring STK11 […]
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific Pte. Ltd. had entered into an agreement with […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it will present new data from its industry-leading haematology portfolio at the 64th American Society of […]
….to bring unique and cost-effective plant-protein ingredients to market by 2023 photo caption:NuCicer co-founders Kathryn Cook (CEO), Douglas Cook (CSO) NuCicer, an agri-food technology company […]
Merck presents two new cosmetic active ingredients for the Asian Pacific market at this year’s in-cosmetics™ Asia that takes place in Bangkok from Nov 1-3: […]
Copyright © 2023 | WordPress Theme by MH Themes
